发布求助

文献互助智能选刊最新文献

Cancer treatment and research communications

查看最新文献

1627

历年发表同类期刊

ISSN：

print: 2468-2942

研究领域：

Medicine-Oncology

Gold OA文章占比：

0.00%

原创研究文献占比：

0.00%

SCI收录类型：

Scopus (CiteScore)

期刊官网：

https://www.journals.elsevier.com/cancer-treatment-and-research-communications

期刊介绍英文：

Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.

CiteScore：

CiteScore	SJR	SNIP	CiteScore排名
4.3	0.793	0.635	学科排名百分位大类：Medicine 小类：Oncology 192 / 404 52% 大类：Biochemistry, Genetics and Molecular Biology 小类：Cancer Research 144 / 230 37%

发文信息

历年影响因子

历年发表

2016年	28
2017年	31
2018年	31
2019年	32
2020年	100
2021年	234
2022年	148

投稿信息

出版国家(地区)：

United Kingdom

接受率：

42%

初审时长：

5 weeks

审稿时长：

56 days

发表时长：

2 weeks

论文处理费：

$2050

出版商：

Elsevier

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2468-2942%5BISSN%5D

Cancer treatment and research communications - 最新文献

Functional status, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio as prognostic factors of one-year survival rate in elderly patients with advanced-stage non-small cell lung cancer.

Pub Date : 2024-12-26 DOI: 10.1016/j.ctarc.2024.100859 Ratna Nurhayati, Aulia Rizka, Cleopas Martin Rumende, Noorwati Sutandyo, Arif Hanafi, Edy Rizal Wahyudi, Hamzah Shatri, Anna Mira Lubis, Em Yunir, Muhammad Firdaus, Yuniar Harris Prayitno, Nadira Nibras Taqiyya

Phase I clinical trial testing the dose escalation and expansion of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin administration (PITHAC) for the management of pleural carcinosis.

Pub Date : 2024-12-17 DOI: 10.1016/j.ctarc.2024.100858 Louis-Emmanuel Chriqui, Etienne Abdelnour-Berchtold, Edoardo Zanfrini, Severine Devesa-Perez, Michel Gonzalez, Thorsten Krueger, Kim Ellefsen, Alice Destaillats, David Bonnet, Martin Hübner, Hasna Bouchaab, Michal Bassani-Sternberg, Solange Peters, Sabrina Cavin, Jean Y Perentes

Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification.

Pub Date : 2024-12-12 DOI: 10.1016/j.ctarc.2024.100857 Youngkyung Jeon, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Kyuehee Choi, Sun Young Jeong, Yeji Jung, Jaeyeon Jang, Dae-Ho Choi, Joohyun Hong, Hyo Jung Kim, Soo Youn Cho, Yeon Hee Park

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。